Results 31 to 40 of about 2,732,208 (333)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
In an attempt to improve global cardiovascular risk prediction, considerable interest has focused on C-reactive protein (CRP), a marker of inflammation that has been shown in multiple prospective epidemiological studies to predict incident myocardial ...
P. Ridker
semanticscholar +1 more source
C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early
COVID‐19 has developed into a worldwide pandemic; early identification of severe illness is critical for controlling it and improving the prognosis of patients with limited medical resources.
Chaochao Tan+7 more
semanticscholar +1 more source
Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature hyperinflammation, and the associated biomarkers may be beneficial for risk stratification. We aimed to investigate the association between several biomarkers, including
I. Huang+4 more
semanticscholar +1 more source
C-reactive protein and atherothrombosis [PDF]
Circulating concentrations of C-reactive protein (CRP), the classical acute phase protein and sensitive systemic marker of inflammation, significantly predict atherothrombotic events and outcome after acute myocardial infarction, demonstrating the key role of inflammation in atherosclerosis and its complications.
Gideon M. Hirschfield, Mark B. Pepys
openaire +2 more sources
C-reactive protein, a hepatic acute phase protein largely regulated by circulating levels of interleukin-6, predicts coronary heart disease incidence in healthy subjects. We have shown that subcutaneous adipose tissue secretes interleukin-6 in vivo.
J. Yudkin+3 more
semanticscholar +1 more source
The renaissance of C reactive protein [PDF]
C reactive protein (CRP) has traditionally been used as an acute phase marker of tissue injury, infection, and inflammation, but the use of high sensitivity assays has recently shown that increased C reactive protein values predict future cardiovascular disease. The C reactive protein response has no diagnostic specificity, but serial measurements can
Mark B. Pepys, Abi Berger
openaire +3 more sources
C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
Background Clinical findings indicated that a fraction of coronavirus disease 2019 (COVID-19) patients diagnosed as mild early may progress to severe cases. However, it is difficult to distinguish these patients in the early stage.
Guyi Wang+11 more
semanticscholar +1 more source
Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19
To the Editor, The outbreak of coronavirus disease‐2019 (COVID‐19) is an emerging global health threat. The healthcare workers are facing challenges in reducing the severity and mortality of COVID‐19 across the world.
Nurshad Ali
semanticscholar +1 more source
C‐reactive protein and ageing [PDF]
SummaryIncreasing evidence shows that C‐reactive protein (CRP) is not only an inflammatory biomarker but also an important risk factor associated with ageing‐related diseases including cardiovascular disease, hypertension, diabetes mellitus, and kidney disease.
Ying Tang+3 more
openaire +2 more sources
Background: Emerging evidence suggests that inflammatory response biomarkers are predictive factors that can improve the accuracy of colorectal cancer (CRC) prognoses.
Jiahui Zhou+10 more
doaj +1 more source